Polar Capital’s AbbVie ABBV Stock Holding History

Polar Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,123,701	Closed	-$85.6M	–	281
2020 Q1	$85.6M	Buy	1,123,701 +75,254	+7%	+$6.41M	0.92%	21
2019 Q4	$92.8M	Buy	1,048,447 +306,537	+41%	+$25.4M	0.81%	21
2019 Q3	$56.2M	Buy	+741,910	New	+$50.9M	0.51%	61
2017 Q2	–	Sell	-80,000	Closed	-$5.21M	–	239
2017 Q1	$5.21M	Sell	80,000 -40,000	-33%	-$2.51M	0.08%	175
2016 Q4	$7.51M	Hold	120,000	–	–	0.12%	166
2016 Q3	$7.57M	Hold	120,000	–	–	0.13%	156
2016 Q2	$7.43M	Sell	120,000 -21,027	-15%	-$1.28M	0.14%	153
2016 Q1	$8.05M	Sell	141,027 -106,539	-43%	-$5.94M	0.15%	146
2015 Q4	$14.7M	Buy	247,566 +17,434	+8%	+$1M	0.27%	109
2015 Q3	$12.5M	Sell	230,132 -341,868	-60%	-$22.3M	0.25%	123
2015 Q2	$38.4M	Buy	572,000 +312,000	+120%	+$20.4M	0.74%	38
2015 Q1	$15.2M	Sell	260,000 -2,448	-0.9%	-$148K	0.29%	106
2014 Q4	$17.2M	Sell	262,448 -28,589	-10%	-$1.8M	0.33%	99
2014 Q3	$16.8M	Sell	291,037 -398,254	-58%	-$22.1M	0.35%	92
2014 Q2	$38.9M	Buy	689,291 +429,781	+166%	+$22.5M	0.83%	26
2014 Q1	$13.3M	Sell	259,510 -424,658	-62%	-$21.5M	0.3%	118
2013 Q4	$36.1M	Buy	684,168 +544,168	+389%	+$26.7M	0.86%	26
2013 Q3	$6.26K	Hold	140,000	–	–	0.17%	181
2013 Q2	$5.79M	Buy	+140,000	New	+$6.12M	0.2%	174

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Polar Capital's ABBV Position: Q2 2020 in Review

Polar Capital sold out of AbbVie (ABBV) in Q2 2020, closing a stake of 1,123,701 shares — an estimated $85.6M sold.

Polar Capital first reported a position in ABBV in Q2 2013 and held it in 19 quarters. The position peaked at $92.8M in Q4 2019. 2,411 funds tracked by Wall St. Rank hold ABBV as of Q2 2020.

Polar Capital reported no remaining AbbVie position as of Q2 2020 after selling out during the quarter.
Polar Capital sold 1,123,701 AbbVie shares in Q2 2020, an estimated $85.6M.
Polar Capital first reported a position in AbbVie in Q2 2013 and held it in 19 quarters.
Polar Capital's AbbVie position peaked at $92.8M in Q4 2019.
2,411 funds tracked by Wall St. Rank held AbbVie as of Q2 2020.

Based on Polar Capital's 13F filing for Q2 2020, filed 14 Aug 2020.